US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kyverna Therapeutics

2.31

+0.270013.24%

Post-market: 2.24-0.0700-3.03%17:19 EDT

Volume:243.58K

Turnover:538.87K

Market Cap:99.84M

PE:-0.69

High:2.32

Open:2.02

Low:2.00

Close:2.04

Loading ...

Overview Company News Filings

BRIEF-Kyverna Therapeutics Files For Offering Of Up To $50 Mln Common Stock From Time To Time - SEC Filing

Kyverna Therapeutics Files for Offering of up to $50 Mln Common Stock From Time to Time - SEC Filing

THOMSON REUTERS

Kyverna Therapeutics Is Maintained at Neutral by HC Wainwright & Co.

Kyverna Therapeutics price target lowered to $4 from $6 at H.C. Wainwright

Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX) and Boundless Bio Inc. (BOLD)

Kyverna Therapeutics Is Maintained at Overweight by Morgan Stanley

Kyverna Therapeutics Inc : Morgan Stanley Cuts Target Price to $20 From $40

THOMSON REUTERS

Kyverna Therapeutics price target lowered to $12 from $13 at UBS

Kyverna Therapeutics Advances CAR T-Cell Therapy Trials

Kyverna Therapeutics Inc Strong Balance Sheet Extends Cash Runway Into 2027 Through Key Clinical And Regulatory Catalysts

Kyverna Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

BRIEF-Kyverna Therapeutics Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing

Kyverna Therapeutics files $250M mixed securities shelf

Kyverna Therapeutics Inc Files for Mixed Shelf of up to $250 Mln - SEC Filing

THOMSON REUTERS

Kyverna Therapeutics Inc: Strong Balance Sheet Extends Cash Runway Into 2027 Through Key Clinical and Regulatory Catalysts

THOMSON REUTERS

Kyverna Therapeutics sees cash and securities sufficient into 2027

Kyverna Therapeutics FY24 EPS ($3.33) Up From ($89.61) YoY.

Calendar of U.S. Earnings Expected in the Week Ahead

Kyverna Therapeutics Inc expected to post a loss of 84 cents a share - Earnings Preview

Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KYTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYTX\",,,,,undefined,":{"symbol":"KYTX","market":"US","secType":"STK","nameCN":"Kyverna Therapeutics","latestPrice":2.31,"timestamp":1746043200000,"preClose":2.04,"halted":0,"volume":243581,"hourTrading":{"tag":"盘后","latestPrice":2.24,"preClose":2.31,"latestTime":"17:19 EDT","volume":4372,"amount":10027.942728000002,"timestamp":1746047972468},"delay":0,"floatShares":17920930,"shares":43218873,"eps":-3.325379,"marketStatus":"Post-Mkt","change":0.27,"latestTime":"04-30 18:19:35 EDT","open":2.02,"high":2.32,"low":2,"amount":538868.0593426,"amplitude":0.156863,"askPrice":2.43,"askSize":1751,"bidPrice":2.11,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.325379,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":4,"adr":0,"listingDate":1707368400000,"exchange":"NASDAQ","adjPreClose":2.04,"preHourTrading":{"tag":"盘前","latestPrice":2.055,"preClose":2.04,"latestTime":"08:38 EDT","volume":1380,"amount":2832.700332,"timestamp":1746016734687},"postHourTrading":{"tag":"盘后","latestPrice":2.24,"preClose":2.31,"latestTime":"17:19 EDT","volume":4372,"amount":10027.942728000002,"timestamp":1746047972468},"volumeRatio":1.37084,"impliedVol":1.1259,"impliedVolPercentile":0.76},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYTX\",,,,,undefined,":{"symbol":"KYTX","floatShares":17920930,"roa":"-46.93%","roe":"-80.74%","lyrEps":-3.325379,"volumeRatio":1.37084,"shares":43218873,"dividePrice":0,"high":2.32,"amplitude":0.156863,"preClose":2.04,"low":2,"week52Low":1.78,"pbRate":"0.37","psRate":"354.03","week52High":17.55,"institutionHeld":0,"latestPrice":2.31,"committee":-0.89195,"eps":-3.325379,"divideRate":0,"volume":243581,"delay":0,"ttmEps":-3.325379,"open":2.02,"prevYearClose":3.74,"prevWeekClose":2.1,"prevMonthClose":1.93,"prevQuarterClose":1.93,"fiveDayClose":2.13,"twentyDayClose":1.98,"sixtyDayClose":3.1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527747638","title":"BRIEF-Kyverna Therapeutics Files For Offering Of Up To $50 Mln Common Stock From Time To Time - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527747638","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527747638?lang=en_us&edition=fundamental","pubTime":"2025-04-16 05:57","pubTimestamp":1744754228,"startTime":"0","endTime":"0","summary":"BRIEF-Kyverna Therapeutics Files For Offering Of Up To $50 Mln Common Stock From Time To Time - SEC FilingApril 15  - Kyverna Therapeutics Inc KYTX.O:KYVERNA THERAPEUTICS FILES FOR OFFERING OF UP TO $50 MILLION COMMON STOCK FROM TIME TO TIME - SEC FILINGSource text: [ID:n0000950170-25-054293]Further company coverage: KYTX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT2H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2527420014","title":"Kyverna Therapeutics Files for Offering of up to $50 Mln Common Stock From Time to Time - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527420014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527420014?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:40","pubTimestamp":1744749639,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT2H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2524531322","title":"Kyverna Therapeutics Is Maintained at Neutral by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524531322","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524531322?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:38","pubTimestamp":1743680280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 03, 2025 07:38 ET (11:38 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"gpt_icon":0},{"id":"2524423460","title":"Kyverna Therapeutics price target lowered to $4 from $6 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2524423460","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524423460?lang=en_us&edition=fundamental","pubTime":"2025-04-03 18:15","pubTimestamp":1743675351,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Kyverna Therapeutics (KYTX) to $4 from $6 and keeps a Neutral rating on the shares following the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-price-target-lowered-to-4-from-6-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-price-target-lowered-to-4-from-6-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYTX"],"gpt_icon":0},{"id":"2524419464","title":"Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX) and Boundless Bio Inc. (BOLD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524419464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524419464?lang=en_us&edition=fundamental","pubTime":"2025-04-03 00:20","pubTimestamp":1743610809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Kyverna Therapeutics, Inc. (KYTX – Research Report) and Boun...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-kyverna-therapeutics-inc-kytx-and-boundless-bio-inc-bold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-kyverna-therapeutics-inc-kytx-and-boundless-bio-inc-bold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4141","NA","KYTX","BOLD","BK4139"],"gpt_icon":0},{"id":"2524156221","title":"Kyverna Therapeutics Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2524156221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524156221?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:42","pubTimestamp":1743511320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 08:42 ET (12:42 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"gpt_icon":0},{"id":"2524194288","title":"Kyverna Therapeutics Inc : Morgan Stanley Cuts Target Price to $20 From $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2524194288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524194288?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:10","pubTimestamp":1743505849,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF0Q9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"gpt_icon":0},{"id":"2523618402","title":"Kyverna Therapeutics price target lowered to $12 from $13 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2523618402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523618402?lang=en_us&edition=fundamental","pubTime":"2025-03-29 23:50","pubTimestamp":1743263405,"startTime":"0","endTime":"0","summary":"UBS lowered the firm’s price target on Kyverna Therapeutics (KYTX) to $12 from $13 and keeps a Buy rating on the shares. The company reported Q4 ea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-price-target-lowered-to-12-from-13-at-ubs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-price-target-lowered-to-12-from-13-at-ubs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYTX"],"gpt_icon":0},{"id":"2523668751","title":"Kyverna Therapeutics Advances CAR T-Cell Therapy Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2523668751","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523668751?lang=en_us&edition=fundamental","pubTime":"2025-03-29 12:02","pubTimestamp":1743220925,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics, Inc. ( ($KYTX) ) has released its Q4 earnings. Here is a breakdown of the information Kyverna Therapeutics, Inc. presented to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kyverna-therapeutics-advances-car-t-cell-therapy-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kyverna-therapeutics-advances-car-t-cell-therapy-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4230","BK4139","KYTX","BK4022","CAR"],"gpt_icon":0},{"id":"2522537306","title":"Kyverna Therapeutics Inc Strong Balance Sheet Extends Cash Runway Into 2027 Through Key Clinical And Regulatory Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2522537306","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522537306?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:12","pubTimestamp":1743109969,"startTime":"0","endTime":"0","summary":"March 27 (Reuters) - Kyverna Therapeutics Inc ::*KYVERNA THERAPEUTICS INC: STRONG BALANCE SHEET EXTENDS CASH RUNWAY INTO 2027 THROUGH KEY CLINICAL AND REGULATORY CATALYSTS  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 27-MAR-202520:02:02.617 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nRSD9LjlFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2522532431","title":"Kyverna Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522532431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522532431?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:02","pubTimestamp":1743109344,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryKyverna Therapeutics Inc KYTX.OQ reported a quarterly adjusted loss of 88 cents per share for the quarter e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA26V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"gpt_icon":0},{"id":"2522354532","title":"BRIEF-Kyverna Therapeutics Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522354532","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522354532?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:53","pubTimestamp":1743108789,"startTime":"0","endTime":"0","summary":"BRIEF-Kyverna Therapeutics Inc Files For Mixed Shelf Of Up To $250 Million - SEC FilingMarch 27  - Kyverna Therapeutics Inc KYTX.O:KYVERNA THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $250 MILLION - SEC FILINGSource text: [ID:n0000950170-25-046162]Further company coverage: KYTX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2522532450","title":"Kyverna Therapeutics files $250M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2522532450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522532450?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:50","pubTimestamp":1743108623,"startTime":"0","endTime":"0","summary":"16:49 EDT Kyverna Therapeutics (KYTX) files $250M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-movi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-files-250m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-files-250m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2522453405","title":"Kyverna Therapeutics Inc Files for Mixed Shelf of up to $250 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522453405","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522453405?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:49","pubTimestamp":1743108541,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2522531641","title":"Kyverna Therapeutics Inc: Strong Balance Sheet Extends Cash Runway Into 2027 Through Key Clinical and Regulatory Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2522531641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522531641?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:22","pubTimestamp":1743106923,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1I1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2522531690","title":"Kyverna Therapeutics sees cash and securities sufficient into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2522531690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522531690?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:10","pubTimestamp":1743106232,"startTime":"0","endTime":"0","summary":"Kyverna reported $286.0M in cash, cash equivalents, and available-for-sale marketable securities as of December 31, 2024. The company expects this ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-sees-cash-and-securities-sufficient-into-2027?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-sees-cash-and-securities-sufficient-into-2027?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2522539112","title":"Kyverna Therapeutics FY24 EPS ($3.33) Up From ($89.61) YoY.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522539112","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522539112?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:09","pubTimestamp":1743106190,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics FY24 EPS ($3.33) Up From ($89.61) YoY.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44523888/kyverna-therapeutics-fy24-eps-3-33-up-from-89-61-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","FC","BLRX","RLMD","FEMY","LNZA","PRGS","GEVO","TSAT","KYTX","ATAI","NNOX","DARE","CRDL","BW","GOVX","PVLA","REKR","UNCY","WGO","WBA","SGML","BCAB","SLRN","SPWH","TLSI","CELC","FTCI","BRZE","NUTX","BHST","EDAP","CLSD","CALC","LULU","AFMD","NCNO","IKT","INMB","MDAI","PVH","SKYH","INR","ADCT","GWH","ANGO","PENG","SDST","FBIO","WKSP"],"gpt_icon":0},{"id":"2521517822","title":"Kyverna Therapeutics Inc  expected to post a loss of 84 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521517822","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521517822?lang=en_us&edition=fundamental","pubTime":"2025-03-22 04:13","pubTimestamp":1742587986,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics Inc  expected to post a loss of84cents a share - Earnings Preview Kyverna Therapeutics Inc KYTX.OQ KYTX.O is expected to show no change in quarterly revenue when it reports  resul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q4214:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"gpt_icon":0},{"id":"2516683666","title":"Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516683666","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516683666?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:05","pubTimestamp":1741035900,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., March 3, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, Chief Executive Officer of Kyverna, will present at the Leerink Partners Global Biopharma Conference in Miami, FL on Monday, March 10, 2025, at 3:00 p.m. ET.A live webcast of the presentation may be accessed via the Investors section of the Kyverna website at ir.kyvernatx.com. A replay of the webcast will be available on the website for 30 days following the conference.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/kyverna-therapeutics-present-leerink-partners-210500221.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kyverna-therapeutics-present-leerink-partners-210500221.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KYTX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":60,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"KYTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.87,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2024-11-13","symbol":"KYTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.77,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1728619200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYTX","date":"2025-04-29","current":-0.695017,"percent":0.954704,"low":-26.836094,"twenty":-10.860591,"median":-3.182759,"eighty":-1.233642,"high":-0.620373,"avg":-6.682591,"sd":7.728111,"marketCap":88598689},"quantilePoints":[{"date":"2024-02-09","current":-25.410847,"twenty":-24.055602,"median":-22.022734,"eighty":-19.989866,"marketCap":1224675750},{"date":"2024-02-16","current":-26.541682,"twenty":-26.641604,"median":-26.505996,"eighty":-25.427787,"marketCap":1279176368},{"date":"2024-02-23","current":-24.230994,"twenty":-26.541682,"median":-25.495549,"eighty":-24.578936,"marketCap":1167812779},{"date":"2024-03-01","current":-24.239916,"twenty":-26.505996,"median":-25.105309,"eighty":-24.54325,"marketCap":1168242754},{"date":"2024-03-08","current":-25.676289,"twenty":-26.318643,"median":-25.069622,"eighty":-24.578936,"marketCap":1237468769},{"date":"2024-03-15","current":-26.354329,"twenty":-26.354329,"median":-25.311608,"eighty":-24.712759,"marketCap":1270146888},{"date":"2024-03-22","current":-23.999034,"twenty":-26.354329,"median":-25.16776,"eighty":-24.239916,"marketCap":1156633422},{"date":"2024-03-28","current":-17.2201,"twenty":-26.32578,"median":-25.042858,"eighty":-23.820602,"marketCap":1039508532},{"date":"2024-04-05","current":-15.927342,"twenty":-26.311505,"median":-24.815357,"eighty":-20.313915,"marketCap":961469941},{"date":"2024-04-12","current":-17.062969,"twenty":-25.959995,"median":-24.578936,"eighty":-17.608641,"marketCap":1030023179},{"date":"2024-04-19","current":-13.577524,"twenty":-25.715544,"median":-24.235455,"eighty":-16.573007,"marketCap":819620788},{"date":"2024-04-26","current":-11.384836,"twenty":-25.597779,"median":-23.86521,"eighty":-16.071617,"marketCap":687256989},{"date":"2024-05-03","current":-10.734886,"twenty":-25.51207,"median":-23.093494,"eighty":-15.443094,"marketCap":648022117},{"date":"2024-05-10","current":-10.427767,"twenty":-25.427787,"median":-18.634621,"eighty":-13.461819,"marketCap":629482562},{"date":"2024-05-17","current":-8.660987,"twenty":-25.252064,"median":-17.663681,"eighty":-11.317698,"marketCap":657507471},{"date":"2024-05-24","current":-7.059414,"twenty":-25.176682,"median":-17.2201,"eighty":-10.732029,"marketCap":535922482},{"date":"2024-05-31","current":-6.996941,"twenty":-25.108877,"median":-16.627288,"eighty":-10.256351,"marketCap":531179806},{"date":"2024-06-07","current":-7.68982,"twenty":-25.053564,"median":-16.309455,"eighty":-9.030538,"marketCap":583780403},{"date":"2024-06-14","current":-8.200961,"twenty":-25.032152,"median":-16.052332,"eighty":-8.699606,"marketCap":622584123},{"date":"2024-06-21","current":-4.560506,"twenty":-24.987544,"median":-15.898773,"eighty":-8.182787,"marketCap":346215409},{"date":"2024-06-28","current":-4.179991,"twenty":-24.930446,"median":-15.76307,"eighty":-7.803407,"marketCap":317328195},{"date":"2024-07-05","current":-4.36173,"twenty":-24.826956,"median":-14.259614,"eighty":-7.683005,"marketCap":331125073},{"date":"2024-07-12","current":-5.457841,"twenty":-24.739524,"median":-13.577524,"eighty":-7.436522,"marketCap":414337494},{"date":"2024-07-15","current":-5.56007,"twenty":-24.730602,"median":-13.28826,"eighty":-7.40699,"marketCap":422098238},{"date":"2024-08-02","current":-4.458278,"twenty":-24.721681,"median":-12.998997,"eighty":-7.379728,"marketCap":338454665},{"date":"2024-08-09","current":-3.873307,"twenty":-24.605701,"median":-11.624103,"eighty":-7.046919,"marketCap":294045964},{"date":"2024-08-16","current":-3.955715,"twenty":-24.550387,"median":-10.892017,"eighty":-5.290869,"marketCap":300302089},{"date":"2024-08-23","current":-4.518382,"twenty":-24.300583,"median":-10.727743,"eighty":-4.552081,"marketCap":343017473},{"date":"2024-08-30","current":-4.558166,"twenty":-24.232778,"median":-10.427767,"eighty":-4.550209,"marketCap":346037753},{"date":"2024-09-06","current":-4.308092,"twenty":-24.091818,"median":-9.970659,"eighty":-4.471909,"marketCap":327053138},{"date":"2024-09-13","current":-3.972766,"twenty":-23.91874,"median":-9.027632,"eighty":-4.36173,"marketCap":301596495},{"date":"2024-09-20","current":-3.932981,"twenty":-23.731387,"median":-8.757535,"eighty":-4.249384,"marketCap":298576215},{"date":"2024-09-27","current":-2.983837,"twenty":-23.401288,"median":-8.2038,"eighty":-4.188739,"marketCap":226520973},{"date":"2024-10-04","current":-2.620093,"twenty":-23.064053,"median":-7.803407,"eighty":-4.107358,"marketCap":198906987},{"date":"2024-10-11","current":-2.585992,"twenty":-21.618758,"median":-7.735255,"eighty":-3.980078,"marketCap":196318176},{"date":"2024-10-18","current":-3.211177,"twenty":-19.474268,"median":-7.570554,"eighty":-3.970492,"marketCap":243779713},{"date":"2024-10-25","current":-2.824699,"twenty":-18.098741,"median":-7.43993,"eighty":-3.926161,"marketCap":214439854},{"date":"2024-10-31","current":-3.023622,"twenty":-17.72781,"median":-7.374617,"eighty":-3.831828,"marketCap":229541252},{"date":"2024-11-08","current":-2.989521,"twenty":-17.672403,"median":-7.116207,"eighty":-3.715421,"marketCap":226952441},{"date":"2024-11-15","current":-1.872701,"twenty":-17.597213,"median":-6.278505,"eighty":-3.207767,"marketCap":207223737},{"date":"2024-11-22","current":-1.556683,"twenty":-17.425798,"median":-5.412407,"eighty":-3.142975,"marketCap":172254731},{"date":"2024-11-29","current":-2.251143,"twenty":-17.188674,"median":-4.774139,"eighty":-3.027032,"marketCap":249100201},{"date":"2024-12-06","current":-1.814179,"twenty":-16.975833,"median":-4.636022,"eighty":-2.984974,"marketCap":200747995},{"date":"2024-12-13","current":-1.740051,"twenty":-16.573007,"median":-4.56385,"eighty":-2.967924,"marketCap":192545389},{"date":"2024-12-20","current":-1.509865,"twenty":-16.354452,"median":-4.538274,"eighty":-2.919045,"marketCap":167074138},{"date":"2024-12-27","current":-1.552781,"twenty":-16.348738,"median":-4.469637,"eighty":-2.836066,"marketCap":171823015},{"date":"2025-01-03","current":-1.529373,"twenty":-16.285886,"median":-4.42582,"eighty":-2.761044,"marketCap":169232719},{"date":"2025-01-10","current":-1.482555,"twenty":-16.158753,"median":-4.36173,"eighty":-2.626913,"marketCap":164052125},{"date":"2025-01-17","current":-1.338201,"twenty":-16.045904,"median":-4.308092,"eighty":-2.550774,"marketCap":148078629},{"date":"2025-01-24","current":-1.322595,"twenty":-15.983052,"median":-4.234207,"eighty":-2.251143,"marketCap":146351764},{"date":"2025-01-31","current":-1.291383,"twenty":-15.904487,"median":-4.202948,"eighty":-1.974139,"marketCap":142898035},{"date":"2025-02-07","current":-1.213354,"twenty":-15.784496,"median":-4.179991,"eighty":-1.846951,"marketCap":134263713},{"date":"2025-02-14","current":-1.186044,"twenty":-15.230253,"median":-4.104819,"eighty":-1.754097,"marketCap":131241700},{"date":"2025-02-21","current":-1.108015,"twenty":-14.458884,"median":-4.025294,"eighty":-1.713911,"marketCap":122607378},{"date":"2025-02-28","current":-1.092409,"twenty":-13.883215,"median":-3.978375,"eighty":-1.612864,"marketCap":120880513},{"date":"2025-03-07","current":-1.01438,"twenty":-13.680373,"median":-3.972766,"eighty":-1.557463,"marketCap":112246191},{"date":"2025-03-14","current":-0.975365,"twenty":-13.461819,"median":-3.964176,"eighty":-1.544978,"marketCap":107929030},{"date":"2025-03-21","current":-0.885632,"twenty":-12.929002,"median":-3.924456,"eighty":-1.490358,"marketCap":97999559},{"date":"2025-03-28","current":-0.919716,"twenty":-12.491893,"median":-3.833552,"eighty":-1.429495,"marketCap":101771131},{"date":"2025-04-04","current":-0.667833,"twenty":-11.767663,"median":-3.76816,"eighty":-1.355367,"marketCap":85133388},{"date":"2025-04-11","current":-0.633933,"twenty":-11.317698,"median":-3.708606,"eighty":-1.299966,"marketCap":80811896},{"date":"2025-04-17","current":-0.620373,"twenty":-11.049147,"median":-3.322005,"eighty":-1.283581,"marketCap":79083299},{"date":"2025-04-25","current":-0.72553,"twenty":-10.892017,"median":-3.196968,"eighty":-1.264073,"marketCap":92488388},{"date":"2025-04-29","current":-0.695017,"twenty":-10.860591,"median":-3.182759,"eighty":-1.233642,"marketCap":88598689}],"updateTime":1746051575449}}}